The cannabinoid CB1 receptor antagonist SR141716A attenuates the memory impairment produced by delta9-tetrahydrocannabinol or anandamide.

Source:http://linkedlifedata.com/resource/pubmed/id/9862397

Download in:

View as

General Info

PMID
9862397